Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine-Restricted Diet Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer
NCT07912346Phase 2Not yet recruiting
- Sponsor
- Xuelei Ma
- Start
- Oct 2026
- Primary completion
- Oct 2026
01
Overview
Phase 2, randomised, open-label trial in rectal cancer (2 arms), sponsored by Xuelei Ma. Primary endpoint: Complete Response Rate. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07912346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07912346.